(Q40428818)

English

Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

1 reference

based on heuristic

inferred from title

human papillomavirus 16

1 reference

based on heuristic

inferred from title

author name string

Hyun-Sun Jin

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Eun-Kyung Park

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Joon-Mo Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sung-Eun NamKoong

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Do-Gang Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Young-Joo Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Heung-Jae Jun

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Byoung-Don Han

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Su-Mi Bae

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Woong-Shick Ahn

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

559-567

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

A Therapy Modality Using Recombinant IL-12 Adenovirus plus E7 Protein in a Human Papillomavirus 16 E6/E7-Associated Cervical Cancer Animal Model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Transgene expression in the rhesus cervix mediated by an adenovirus expressing beta-galactosidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.046

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.01.046

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40428818&oldid=1897736857"